A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Movendo and Maragal Medical Partner to Predict the Fall Risk of Older Adults With New Robotic System and Artificial Intelligence

Maragal Medical integrates Movendo Technology’s robotic system hunova© and Silver Index© into a free community screening and fall risk prevention program for Medicare patients

Movendo Technology has partnered with Maragal Medical to integrate Movendo’s robotic system hunova© into a fall prevention screening for older patients.

“Maragal Medical is thrilled to announce that we will be offering complimentary fall prevention screenings at our clinic starting in January 2022,” says Dr. Timothy Gallagher, CEO of Maragal Medical.“ Falls among older adults, particularly those over the age of 65 and on Medicare, are a leading cause of unintentional injuries, traumatic hospital admissions, and injury related deaths. Even minor falls can trigger a fear of falling in older persons, leading them to limit their activity and lose their strength and independence.”

Every year 1 out of every 4 adults aged over 65 reported at least one fall, leading to 9 million fall related injuries, often resulting in hospitalization, trauma or even death. 95% of all hip fractures are caused by falling, with 3 out of 4 being women.

The hunova© is a programmable robotic medical device consisting of two independent electromechanical movable platforms, one at foot level and one at seat level. The device, which can deliver more than 200 evaluations and exercises for postural control, stretching, muscle strengthening, balance, core stability and proprioception, has a unique feature to predict and prevent the risk of falls:

The Silver Index© simulates the static and dynamic “perturbative” elements at the origin of falls in a controlled way, highlighting the specific deficiency of the person and providing personalized rehabilitative intervention. The evaluation is progressive, and thanks to the use of Artificial Intelligence with its machine learning algorithms, the best biomechanical and clinical parameters have been selected to obtain the most accurate prediction.

“Over the past two years, utilizing our cutting-edge hunova robotics technology, we have seen firsthand how objective evaluations and individualized rehabilitation protocols aid our patients in improving flexibility, strength and balance,” emphasized Dr. Michael Marciello, Medical Director of Maragal Medical. “We are confident, that by implementing a formal Fall prevention program at our medical clinic, utilizing hunova’s Silver Index assessment protocol, we will be able to give back to our local community and prevent falls.”

“We are proud to partner with Maragal Medical on this important community project,” said Frank Menzler, Executive VP and General Manager North America of Movendo. “Using hunova and its digital solution Silver Index, it is now possible to efficiently evaluate and objectively predict the risk of fall and support people in reducing such risk through personalized training and treatment, and ultimately improve their quality of life. The Silver Index is also proven to be an important tool for population health by our collaboration with multinational insurance companies, such as GENERALI in Europe.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy